Market Update (NASDAQ:CELG): Organizational Changes Strengthen Leadership Team and Position Celgene for Long-Term Growth

[Business Wire] – Celgene Corporation today announced organizational changes that will position the Company for continued long-term growth. Effective March 1, 2016: Read more on this. Celgene Corporation (CELG) , currently valued at $80.12B, opened at $109.27. Looking at today’s trading action, the company’s one day range from $99.33 to $109.96 with its 52-week range being $92.98 to $140.72. CELG shares are currently priced at 23.17x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.15x earnings multiple. Consensus earnings for the current quarter by the 20 sell-side analysts covering the stock is an estimate of $1.28 per share, which would be $0.27 better than the year-ago quarter and a $0.01 sequential decrease. The full-year EPS estimate is $4.83, which would be a $1.12 better than last year. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $2.54 Billion. If realized, that would be a 21.53% increase over the year-ago quarter. Recently, Sun Trust Rbsn Humphrey Initiated CELG at Buy (Jan 8, 2016). Previously, Sun Trust Rbsn Humphrey Initiated CELG at to Buy. When considering if the stock is under or overvalued, the average price target is $143.35, which is 31.19% above where the stock opened this morning. See more in (NASDAQ:CELG) Similar Articles: Company Update (NASDAQ:CELG): Celgene Reports Third Quarter 2015 Operating and Financial Results Market Update (NASDAQ:CELG): Celgene Corporation Commences Tender Offer for Receptos, Inc. Company Update (NASDAQ:CELG): Robbins Arroyo LLP: Acquisition of Receptos, Inc. (RCPT) by Celgene Corporation (CELG) May Not Be in Shareholders’ Best Interests
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.